CRDF.OQ - Cardiff Oncology Inc
Cardiff Oncology Inc
William Blair & Company

Near-Term Updated Data Could Clarify Onvansertib’s Profile; Phase III Trial Likely to Require Additional Capital

公司
CRDF.OQ
日期
2026-02-24
分析师
Andy T. Hsieh, PHD
页数
7
需要登录
请登录后购买研报或生成音频内容。